Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience

J Pharm Health Care Sci. 2023 Apr 14;9(1):16. doi: 10.1186/s40780-023-00284-z.

Shinya Tsuboi^{1

2}, Tatsuya Hayama^{1

2}, Katsuhiro Miura^{3

4}, Akihiro Uchiike^{1

2}, Daisuke Tsutsumi¹, Takashi Yamauchi^{1

2}, Yoshihiro Hatta⁵, Susumu Ootsuka¹

¹ Department of Pharmacy, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
² Tumor Center, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.
³ Tumor Center, Nihon University Itabashi Hospital, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan. miura.katsuhiro@nihon-u.ac.jp.
⁴ Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan. miura.katsuhiro@nihon-u.ac.jp.
⁵ Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi city, Tokyo, 173-8610, Japan.

No abstract available

Publication types